about
Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validationClinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable anginaTroponin assay use in the emergency department for management of patients with potential acute coronary syndrome: current use and future directionsPotential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.Value of heart-type fatty acid-binding protein (H-FABP) for emergency department patients with suspected acute coronary syndromeClinical significance of ischemia-modified albumin in the diagnosis of doxorubicin-induced myocardial injury in breast cancer patients.Biomarkers: hopes and challenges in the path from discovery to clinical practice.No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome.Elevated cardiac troponin in the early post-operative period and mortality following ruptured abdominal aortic aneurysm: a retrospective population-based cohort studyCell-free DNA and outcome in sepsisIncrease in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.Dissection of mechanisms of a chinese medicinal formula: danhong injection therapy for myocardial ischemia/reperfusion injury in vivo and in vitro.A gold nanoparticles enhanced surface plasmon resonance immunosensor for highly sensitive detection of ischemia-modified albumin.Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes.Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9.Medical emergencies: atrial fibrillation and myocardial infarction.Neutrophil gelatinase-associated lipocalin as diagnostic and prognostic tool for cardiovascular disease and heart failure.Chest pain with elevated troponin assay in adolescents.Metabolomics in the diagnosis of acute myocardial ischemia.Copeptin-marker of acute myocardial infarction.Prognostic significance of elevated troponin in non-cardiac hospitalized patients: a systematic review and meta-analysis.Serum ischaemia-modified albumin level is an irrelevant predictive factor for ischaemic duration in mesenteric ischaemia.Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.Values of troponin T and myoglobin predictive of non-cardiac ischemia in rats.The role of ischemia modified albumin in acute pulmonary embolism.Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction.Serum nitric oxide level could be a predictive biomarker for detection of critical ischaemia duration.Mechanisms Involving Myocardial Injury in Tropical Stings and Bites.Valproic acid treatment attenuates caspase-3 activation and improves survival after lethal burn injury in a rodent model.
P2860
Q26778915-B86CC7B0-B553-42E1-9D5C-BC0208C022B2Q26859111-CE4A71D1-5B78-4475-9000-B93B03BCEDD2Q28073071-3E709716-AA00-4CA8-8822-065950E9F369Q33897327-B74E58E2-5ECF-4413-AD74-B2D9F3FD1F18Q34405801-71B2AEA2-7EC8-4D2B-B5CD-FCD370F38EBAQ35041318-C83D7EF1-743E-4FA7-B437-3F6AD0535718Q35471494-1E95777D-525A-422C-A3FB-83002DF80E3DQ35692595-B4580F5C-B885-440D-B610-A9B246DD4A13Q35941412-31119EE5-ECE9-4A3B-8656-5CC58545BED9Q36633988-4C645E4A-8735-45DD-AB01-5001BD3087ABQ36902576-8F001208-8537-417B-A752-F0A12AC1E87BQ36931261-2F9EEB69-44FE-4349-8EE1-473460A93607Q36938805-C66D07F1-44FF-4B48-8AE1-C4E68B6EA56CQ37383007-C4B2D594-84A1-4889-A264-4BF096F2FE0BQ37655951-15C44EBD-4932-4BAD-9F63-BE04D5AE9184Q37681556-E97CC286-2E85-4A81-853A-F1438B7515E0Q37709981-940E0C2E-5BE0-4166-AD1F-71118E1EE459Q38064908-D262AAF9-EA41-4BEA-B3F2-3309CE3E8FDAQ38093260-B1928B4C-9890-4278-806D-6376B6D6517CQ38104486-79EBAED2-0285-4DF8-A373-44B0A9651AFFQ38132702-87EFAB66-662E-49E6-B4FB-00AA236C7A9DQ38213084-3B0DA16F-7842-4798-A642-7E6F3025DD95Q38259338-038E33FA-A5D7-4E13-BE3F-0A88CB048B0BQ39351983-3662EED2-808A-4479-99D9-165239746BA4Q39379692-6F27465D-47F4-44D2-B6AA-E9981A1F6380Q41132564-B4A0EF89-877D-4090-A21E-2C5F22ACC433Q42231055-F3FC924F-BF66-4EC5-8925-3A38A48E8597Q42439863-DF6D28A6-C7D5-45BD-A131-F91EC232D2C9Q46001293-86EEA41F-0E22-44BE-907F-EED0BE8CEB91Q47162202-6481A782-8B26-4887-A782-87A46039B88CQ48118649-8F264638-5711-47FF-AED9-7DE1530B58C7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biomarkers in acute myocardial injury.
@en
Biomarkers in acute myocardial injury.
@nl
type
label
Biomarkers in acute myocardial injury.
@en
Biomarkers in acute myocardial injury.
@nl
prefLabel
Biomarkers in acute myocardial injury.
@en
Biomarkers in acute myocardial injury.
@nl
P2093
P1476
Biomarkers in acute myocardial injury.
@en
P2093
Alan S Maisel
Alejandro De La Parra Landa
Arrash Fard
Ben A Kipper
Devin W Kehl
Navaid Iqbal
P304
P356
10.1016/J.TRSL.2011.11.002
P577
2011-12-07T00:00:00Z